Biogen Inc (BIIB)
208.98
+6.52
(+3.22%)
USD |
NASDAQ |
Apr 26, 16:00
209.50
+0.52
(+0.25%)
After-Hours: 17:33
Biogen Total Liabilities (Quarterly): 11.35B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.35B |
| December 31, 2023 | 12.05B |
| September 30, 2023 | 13.71B |
| June 30, 2023 | 10.70B |
| March 31, 2023 | 10.81B |
| December 31, 2022 | 11.17B |
| September 30, 2022 | 12.09B |
| June 30, 2022 | 13.22B |
| March 31, 2022 | 12.39B |
| December 31, 2021 | 12.92B |
| September 30, 2021 | 12.92B |
| June 30, 2021 | 13.26B |
| March 31, 2021 | 13.19B |
| December 31, 2020 | 13.93B |
| September 30, 2020 | 14.19B |
| June 30, 2020 | 14.22B |
| March 31, 2020 | 13.58B |
| December 31, 2019 | 13.90B |
| September 30, 2019 | 13.49B |
| June 30, 2019 | 13.34B |
| March 31, 2019 | 12.62B |
| December 31, 2018 | 12.26B |
| September 30, 2018 | 11.73B |
| June 30, 2018 | 11.70B |
| March 31, 2018 | 12.05B |
| Date | Value |
|---|---|
| December 31, 2017 | 11.05B |
| September 30, 2017 | 10.22B |
| June 30, 2017 | 10.19B |
| March 31, 2017 | 9.728B |
| December 31, 2016 | 10.75B |
| September 30, 2016 | 9.990B |
| June 30, 2016 | 10.11B |
| March 31, 2016 | 10.35B |
| December 31, 2015 | 10.13B |
| September 30, 2015 | 10.16B |
| June 30, 2015 | 4.186B |
| March 31, 2015 | 3.550B |
| December 31, 2014 | 3.501B |
| September 30, 2014 | 3.273B |
| June 30, 2014 | 3.353B |
| March 31, 2014 | 3.089B |
| December 31, 2013 | 3.242B |
| September 30, 2013 | 3.125B |
| June 30, 2013 | 2.939B |
| March 31, 2013 | 2.825B |
| December 31, 2012 | 3.166B |
| September 30, 2012 | 2.969B |
| June 30, 2012 | 2.892B |
| March 31, 2012 | 2.805B |
| December 31, 2011 | 2.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.70B
Minimum
Jun 2023
14.22B
Maximum
Jun 2020
12.82B
Average
13.20B
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 53.14B |
| Bristol-Myers Squibb Co | 65.67B |
| Gilead Sciences Inc | 39.38B |
| AbbVie Inc | 124.31B |
| Regeneron Pharmaceuticals Inc | 7.107B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.57B |
| Shareholders Equity (Quarterly) | 15.21B |
| Debt to Equity Ratio | 0.4299 |
| Current Ratio | 2.096 |
| Net Debt Paydown Yield | -0.17% |